Published in Vaccine Weekly, February 16th, 1998
The company understands that the vaccine is to be used by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH) in clinical trials involving laboratory and healthcare workers who are "at risk" from exposure to the virus in the United States and other countries.
The company has delivered more than 1,000 doses of the vaccine to the NIH for use in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly